Tumor Budding and E-Cadherin Loss as Robust Prognostic Markers in Pancreatic Ductal Adenocarcinoma: A Study in a Turkish Patient Cohort. [PDF]
Özcan TB, Pasaoglu E, Gülçiçek OB.
europepmc +1 more source
Anticancer potential of berberine: Molecular pathways and current clinical trial perspectives
Abstract Cancer is constantly rising mortality rates due to its late prognosis, poor management, and expensive treatment. Multi‐sectoral approaches for cancer management include hygienic practices, synthetic drug exploitation, radiation therapy, and diet modifications.
Muhammad Maaz +10 more
wiley +1 more source
[Retracted] β‑elemene decreases cell invasion by upregulating E‑cadherin expression in MCF‑7 human breast cancer cells. [PDF]
Zhang X, Zhang Y, Li Y.
europepmc +1 more source
ABSTRACT Bilateral prophylactic mastectomy (BPM) or contralateral risk‐reducing mastectomy (CRRM) are considered in CDH1 carriers as a strategy to reduce lobular breast cancer (LBC) risk in women. In this study we aimed to evaluate the overall number of these procedures reported in literature.
Giovanni Corso +13 more
wiley +1 more source
Immunohistochemical expression of epithelial mesenchymal transition proteins ZEB1 and E-cadherin in oral leukoplakia and oral squamous cell carcinoma. [PDF]
Panchannavar GS, Angadi PV.
europepmc +1 more source
The Prognostic Value of CIP2A and Its Association with CD31, E-Cadherin, and pAMPK in Lung Cancer. [PDF]
Lee PY +5 more
europepmc +1 more source
Systematic Search for Blood-Brain Barrier Modulating Peptides Based on Exhaustive E-Cadherin Domain-Domain Docking. [PDF]
He J, Siahaan TJ, Kuczera K.
europepmc +1 more source
NMD-insensitive CDH1 mutation as a mechanism for retained E-cadherin protein expression in lobular carcinoma in situ (LCIS). [PDF]
Christgen M, Bartels S, Kreipe H.
europepmc +1 more source
Comparative study of E-cadherin expression between reticular, erosive oral lichen planus and lichenoid lesions. [PDF]
Maleki L +3 more
europepmc +1 more source

